Intellia Therapeutics NTLA Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$96.23M+15.8% | -$95.79M+25.7% | -$101.32M+25.3% | -$101.26M+31.1% | -$114.33M-6.4% | ||
| $2.2M-11.8% | $2.38M-7.2% | $2.4M-7.7% | $2.5M-3.8% | $2.5M-0.6% | ||
| $13.48M-38.3% | $16.74M-57.7% | $19.6M-50.5% | $22.04M-46.1% | $21.84M-36.1% | ||
| -$117.35M+21.2% | -$69.29M+18.7% | -$76.9M+9.4% | -$99.62M-71.2% | -$148.93M-23.4% | ||
| $79K-89.3% | $126K-87.2% | $29K-97.7% | $239K-76.4% | $735K-70.7% | ||
| $66.31M-29.7% | $27.53M-81.8% | $0+100% | $106.91M+542% | $94.33M+1,499% | ||
| $33.57M— | $1.98M-14.7% | $114.86M+39.7% | $14.65M-64.5% | $0-100% | ||
| -$17.47M+68.0% | -$39.77M— | $37.22M+459% | —— | -$54.6M+0.3% | ||
| -$117.43M+21.5% | -$69.41M+19.5% | -$76.93M+10.7% | -$99.86M-68.7% | -$149.67M-21.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Intellia Therapeutics generate?
- Intellia Therapeutics (NTLA) generated -$363.2M in operating cash flow over the trailing twelve months.
- What is Intellia Therapeutics's free cash flow?
- After $473.0K of capital expenditures, Intellia Therapeutics's free cash flow was -$363.6M over the trailing twelve months, up 4.6% year over year.
- Where does Intellia Therapeutics's cash flow data come from?
- Every line is extracted from Intellia Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
